Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).

× No keyword cloud information.

20 in total

1. High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk.

Authors: H Wilke; P Preusser; U Fink; W Achterrath; L Lenaz; M Stahl; C Schober; H Link; H J Meyer; B Lucke
Journal: Invest New Drugs Date: 1990-02 Impact factor: 3.850

2. Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models.

Authors: Kader Yagiz; Tiffany T Huang; Fernando Lopez Espinoza; Daniel Mendoza; Carlos E Ibañez; Harry E Gruber; Douglas J Jolly; Joan M Robbins
Journal: Neuro Oncol Date: 2016-05-10 Impact factor: 12.300

3. The l-Alanosine Gene Cluster Encodes a Pathway for Diazeniumdiolate Biosynthesis.

Authors: Tai L Ng; Monica E McCallum; Christine R Zheng; Jennifer X Wang; Kelvin J Y Wu; Emily P Balskus
Journal: Chembiochem Date: 2019-12-19 Impact factor: 3.164

Review 4. The iatrogenic leukaemias induced by radio- and/or chemotherapy.

Authors: Y Najean
Journal: Med Oncol Tumor Pharmacother Date: 1987

5. Clinical pharmacokinetics of oral CCNU (lomustine).

Authors: F Y Lee; P Workman; J T Roberts; N M Bleehen
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

6. Capillary gas chromatography and thermionic N-P-specific detection of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in stability and pharmacokinetic studies.

Authors: A El-Yazigi; C R Martin
Journal: Pharm Res Date: 1988-04 Impact factor: 4.200

7. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.

Authors: P Bedford; M R Berger; G Eisenbrand; D Schmähl
Journal: J Cancer Res Clin Oncol Date: 1984 Impact factor: 4.553

8. Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity. III. Ultrastructural characterization of bile duct injury.

Authors: N W Kretschmer; P J Boor; R A el Azhary; A E Ahmed; E S Reynolds
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

9. N-4-iodophenyl-N'-2-chloroethylurea, a novel potential anticancer agent with colon-specific accumulation: radioiodination and comparative in vivo biodistribution profiles.

Authors: Emmanuelle Mounetou; Elisabeth Miot-Noirault; René C Gaudreault; J Claude Madelmont
Journal: Invest New Drugs Date: 2009-02-10 Impact factor: 3.850

10. Metronomic administration of lomustine following palliative radiation therapy for appendicular osteosarcoma in dogs.

Authors: Megan E Duffy; Christie L Anderson; Kevin Choy; Janean L Fidel
Journal: Can Vet J Date: 2018-02 Impact factor: 1.008